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Accumulating evidence has indicated that microRNAs (miRNAs) act as critical epigenetic regulators
in tumor carcinogenesis. Here, we report that miR-199a-3p was signiﬁcantly upregulated in gastric
cancer (GC) cell lines and tissues. Functional studies demonstrated that miR-199a-3p dramatically
increased cell proliferation and suppressed cell apoptosis both in vitro and in vivo. Furthermore,
the transcriptional regulator zinc ﬁngers and homeoboxes 1 (ZHX1) was identiﬁed as one of the
direct downstream targets of miR-199a-3p, miR-199a-3p bound to the ZHX1 30 untranslated region
(30UTR) to regulate ZHX1 protein expression. In addition, the expression of miR-199a-3p was inver-
sely associated with that of ZHX1 in GC cell lines. Overexpression of miR-199a-3p in SGC-7901 cells
inhibited ZHX1 expression, while reduction in miR-199a-3p by inhibitors in NCI-N87 cells enhanced
ZHX1 expression. Moreover, restoring ZHX1 expression in SGC-7901/miR-199a-3p cells inhibited the
cell proliferation induced by miR-199a-3p. Taken together, these ﬁndings suggest that miR-199a-3p
may function as a novel tumor promoter in GC and its oncogenic activity may involve the direct
targeting and inhibition of ZHX1.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Gastric cancer (GC) is one of the most common cancers and the
second lethal cancer worldwide [1]. Although mortality rates of
GC have decreased signiﬁcantly, the absolute number of GC
cases and deaths is still a big burden [2]. Therefore, a better compre-
hending of the molecular pathways related to the carcinogenesis of
GC is essential to reduce GC mortality. Evidence collected to date
has indicated that the microRNAs (miRNAs) are newfangled regula-
tors of tumor development and new targets for cancer treatments in
GC [3].
MiRNAs are small non-coding, single-stranded endogenous RNA
molecules that degrade mRNAs and suppress protein expression
[4]. Compelling evidences had proved that miRNAs modulate most
cellular processes involved in tumor biological behaviors such as
cell proliferation, apoptosis, differentiation and metastasis [5].
Abnormal expression of miRNAs, which function as oncogenes or
tumor suppressor genes, can exist in many malignant tumors and
is closely related to the occurrence and development of tumors[6]. Although plenty of miRNAs in relation to GC have been studied,
the underlyingmechanism of these miRNAs in carcinogenesis of GC
remains to be investigated.
MiR-199 was identiﬁed from mouse skin cells and it was
cloned from the human osteoblast sarcoma cell [7]. The expres-
sion levels of miR-199a-3p vary in different tumor cells, and
highly expressed miR-199a-3p can role as a potential oncogene
in breast cancer [8], while suppressed miR-199a-3p can act as a
possible tumor suppressor in hepatocellular carcinoma [9]. Our
previous study found that the expression of miR-199a-3p in the
plasma was substantially up-regulated in GC [10] and that
miR-199a-3p in the plasma could serve as a potential diagnostic
marker for early GC [11]. MiR-199a has been reported in recent
studies on GC [12–14], while the role of miR-199a-3p in GC
progression has not been explored.
In the present study, we demonstrated a general increase in the
miR-199a-3p expression level in 52 GC tissues compared with the
non-tumor tissues, and found that themiR-199a-3p expression lev-
els are associated with tumor invasion and the TNM stage. In
addition, we discovered that miR-199-3p could induce the growth
and inhibit apoptosis of GC cells both in vitro and in vivo by directly
targeting the transcription factor zinc ﬁngers and homeobox 1
(ZHX1).
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2.1. Cell culture and clinical specimens
Preparation of clinical samples, gastric cancer cell lines AGS,
MKN-45, MKN-28, SGC-7901, NCI-N87, BGC-823, immortalized
normal gastric mucosal epithelial cell line (GES-1) and human
embryonic kidney cell line 293T (HEK 293T) was described in
[15]. The six gastric cell lines and GES-1 cells were grown in
RPMI-1640, while HEK 293T was grown in DMEM (Sigma, St. Louis,
MO, USA) with 10% fetal bovine serum (FBS) at 37 C in a humidi-
ﬁed atmosphere with 5% CO2.
2.2. RNA isolation and quantitative real-time PCR (qRT-PCR)
Total RNA was isolated from cell lines and clinical specimens
using an mirVana™ miRNA Isolation Kit (Applied Biosystems, Fos-
ter City, CA, USA) according to the manufacturer’s instructions. The
expression level of miR-199a-3p in cell lines and tissues was mea-
sured by qRT-PCR according to the TaqmanMicroRNA Assays pro-
tocol (Applied Biosystems) and normalized using U6 small nuclear
RNA (RNU6B; Applied Biosystems) by the 2DCT method. The rela-
tive expression ratio of miR-199a-3p in each paired tumor and
non-tumor tissue was calculated by the 2DDCT method. The
expression level of ZHX1mRNA was measured by qRT-PCR accord-
ing to the SYBR Green real-time PCR Assay protocol (Applied Bio-
systems). The GAPDH mRNA level was used for normalization.
The expression level of ZHX1 mRNA relative to GAPDH mRNA
was calculated using the 2DCT method.
2.3. Transient transfection
MiR-199a-3pmimics (dsRNA oligonucleotides), negative control
(NC), miR-199a-3p inhibitor, and inhibitor negative control were
purchased from GenePharma (Shanghai, China). The pEGFP-ZHX1
(1–873) plasmid was donated by Prof. Kazuya Yamada (Matsumoto
University Graduate School of Health Science). Transfection of cells
with oligonucleotides was performed using Lipofectamine 2000
Reagent (Invitrogen, Carlsbad, CA, USA) at a ﬁnal concentration of
100 nM. Transfection efﬁciency was monitored by qRT-PCR.
2.4. Cell proliferation assay
At 24 h post transfection with miR-199a-3p mimics/inhibitors
or control oligonucleotides, cells were seeded into 96-well plates
(1.5  10^5 cells/well) and cell proliferation was documented
every 24 h for 4 days. Cell proliferation was assessed in triplicates
by the water-soluble tetrazolium salt (WST) assay using the Cell
Counting Kit-8 (Dojindo, Kumamoto, Japan) following the manu-
facturer’s instructions.
2.5. Soft agar colony formation assay
MiRNA mimics/inhibitors-transfected SGC-7901/NCI-N87 cells
were resuspended with 0.3% soft agar (A9045, low gelling temper-
ature, Sigma–Aldrich, St. Louis, MO, USA) in RPMI 1640 containing
10% FBS and layered on 0.6% solidiﬁed agar in RPMI 1640 contain-
ing 10% FBS in six-well plates (1  10^3 cells/well) 24 h post trans-
fection. The plates were incubated for 2 weeks. Colonies containing
at least 50 cells were counted.
2.6. Flow cytometric analysis for apoptosis
One day before transfection, 2  10^6 cells were seeded
into six-well culture plates without antibiotics. The cells weretransfected with miR-199a-3p mimics/miR-199a-3p inhibitor or
their respective controls. Forty-eight hours after transfection, cells
were harvested and stained with the AnnexinV/PI double staining
kit (BD Biosciences, USA) according to the manufacturer’s protocol.
Apoptotic cells were assessed in triplicates by ﬂow cytometry on a
FACScan (Beckman Instruments, Fullerton, CA, USA). Experiments
were repeated three times.
2.7. Lentiviral transfection for stable expression clones
LV3-pGLV-H1-GFP+Puro plasmids with hsa-miR-199a-3p
inhibitor or control oligonucleotides, namely LV-anti-miR-199a-
3p and LV-anti-miR-NC, were purchased from GenePharma
(Shanghai, China). Lentivirus transfections were performed accord-
ing to the manufacturer’s instructions to establish anti-miR-199a-
3p-expressing stable clones in NCI-87 cells (NCI-N87/anti-miR).
The control clones (NCI-N87/anti-NC) were produced by a similar
method. The miR-199a-3p expression level was examined by
qRT-PCR using U6 RNA as an endogenous control.
2.8. Tumour xenograft model, tumorigenicity assay and
immunohistochemistry
All animal studies complied with protocols approved by the
Committee on Animal Care in Shanghai Jiao Tong University School
of Medicine. Cells (100 ml, 2  10^6 cells) from stable transfected
lines LV-anti-miR-199a-3p and LV-anti-miR-NC were collected
and inoculated subcutaneously into the right ﬂank of 4-week-old
male nude mice. Five mice were used for each group. Mice were
checked weekly, and tumor nodules were measured with a caliper.
After the mice were sacriﬁced, all tumor grafts were excised,
weighed, harvested, ﬁxed, embedded and examined histologically.
2.9. Cloning of 30UTR of ZHX1 into pMIR-REPORT luciferase vector
The 30UTRs of ZHX1 was synthesized according to a 59-bp
genomic fragment containing the predicted miR-199a-3p binding
sites. The mutant ZHX1 30UTR construct was designed to mutate
three intermittent nucleotides complementary to the miR-199a-
3p seed-region. Both strands were annealed and cloned into the
Hind III-MluI sites of the pMIR-REPORT miRNA expression reporter
vector (Applied Biosystems).
2.10. Western blot analysis
ZHX1 protein levels were quantiﬁed by standard immunoblot
procedures, using rabbit anti-human ZHX1 antibody (1:2000,
Abcam, USA). Monoclonal anti-GAPDH (1:5000, Abcam, USA) was
used for loading control.
2.11. Statistical analysis
Student’s t test or one-way ANOVA were used for statistical
analysis when appropriate. All statistical analyses were performed
using SPSS 19.0 (SPSS Inc., Chicago, IL, USA). A two-tailed value of
P < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. The expression of miR-199a-3p is up-regulated in GC and
correlates with TNM stage and tumor invasion
MiR-199a-3p expression was examined by quantitative real
time RT-PCR (qRT-PCR) in GC cell lines and GES-1. As shown in
Fig. 1 A, miR-199a-3p was generally upregulated in all GC cell lines
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evaluated by qRT-PCR in tumor samples and their matched non-
tumor samples from 52 GC patients (Fig. 1B). The average expres-
sion level of miR-199a-3p was signiﬁcantly upregulated in tumor
samples compared with the non-tumor samples (Fig. 1C). These
results strongly indicated that miR-199a-3p was signiﬁcantly
upregulated in GC cells and tissues.
The correlations between expression level of miR-199a-3p and
clinicopathologic factors in GC were examined. Clinicopathologic
characteristics of 52 GC patients are shown in Table 1. Among
the 52 GC tissues, 69.2% (36/52) of the tumor tissues exhibited
upregulation of miR-199a-3p (relative expression ratio < 1.0). In
addition, 57.6% (30/52) of GC samples showed increased expres-
sion of miR-199a-3p under the twofold cut-off (relative expression
ratio < 0.5). 52 cases were divided into two groups: miR-199a-3pFig. 1. Upregulation of miR-199a-3p expression in GC cell lines and tissues
compared with the corresponding controls. (A) Relative expression of miR-199a-3p
and ZHX1 in six GC cell lines and GES-1 was carried out by qRT-PCR. (B) Relative
expression of miR-199a-3p in 52 GC patient tissues compared with its adjacent
non-tumor tissues. QRT-PCR results are shown 44CT values. (C) The mean and
standard deviation of miR-199a-3p expression levels in 52 surgical specimens of GC
tissues and matched non-tumor tissues were shown. Data are presented 2^(4CT)
values (⁄⁄⁄P < 0.001).low expression (n = 22) and miR-199a-3p high expression
(n = 30). The miR-199a-3p high-expression group had inclinations
toward the TNM stage (P = 0.037) and invasion depth (P = 0.08).
However, there were not any relationships between the miR-
199a-3p expression and other clinicopathological factors.
3.2. Ectopic expression of miR-199a-3p induces GC cell proliferation
Considering that miR-199a-3p is signiﬁcantly upregulated in
GC, it may role as a tumor promoter. Therefore, to further investi-
gate the inducing function of miR-199a-3p in GC, SGC-7901 cells,
which presented a low level of miR-199a-3p, were transfected
with miR-199a-3p mimics or negative control (NC). In addition,
NCI-N87 cells, which expressed a high level of miR-199a-3p, were
transfected with miR-199a-3p inhibitors or its control. The WST
cell growth assay was performed on the transfected cell lines. As
indicated in Fig. 2A and B (3.4 ± 0.2 VS 2.7 ± 0.4, P < 0.05;
1.5 ± 0.4 VS 1.0 ± 0.1, P < 0.01), SCG-7901 cells transfected with
miR-199a-3p mimics showed marked cell growth induction while
NCI-N87 cells transfected with inhibitors showed signiﬁcant cell
growth inhibition. To further identify the effect of miR-199a-3p
on cell growth, the soft agar colony formation assay on transfected
cells was performed. The number of colonies of SGC-7901 cells
transfected with miR-199a-3p mimics was higher than half that
of the control (161% ± 25.2% VS 51.7% ± 27.9%, P < 0.01, Fig. 2C).
Opposite results were observed with NCI-N87 cells transfected
with inhibitors (126.8% ± 9.42% VS 163.5% ± 14.6%, P < 0.01,
Fig. 2D). These results exhibited that miR-199a-3p can promote
the tumorigenicity of GC cells in vitro.
3.3. Downregulation of miR-199a-3p expression promotes GC cells
apoptosis
GC cell apoptosis analysis was carried out to elucidate the
mechanism of miR-199a-3p-mediated cell growth promotion in
GC cells. The results showed that comparing with the control
group, SGC-7901 cells transfected with miR-199a-3p mimicsTable 1
Relationship between miR-199a-3p expression level and clinicopathologic parame-
ters in 52 GC cases.
Clinicopathologic parameters MiR-199a-3p expression P-value
Low (N = 22) High (N = 30)
Ages (years)
P60 16 19 0.390
<60 6 11
Gender
Female 6 12 0.390
Male 16 18
Tumor size (cm)
P5 10 9 0.382
<5 12 21
Differentiation
Well, moderately 13 9 0.054
Poorly, undifferentiated 9 21
Location
Distal third 17 25 0.752
Middle third, proximal third 5 5
Tumor invasion
T1, T2 8 3 0.037*
T3, T4 14 27
Lymph node metastasis
Yes 12 26 0.058
No 10 4
TNM stage
I,II 10 3 0.008*
III,IV 12 27
* P-value < 0.05 was considered statistically signiﬁcant.
Fig. 2. Up/down expression of miR-199a-3p promotes/inhibits the proliferation of GC cells in vitro. Cell proliferation was evaluated by the WST assay in SGC-7901 cells (A)
and NCI-N87 cells (B). SGC-7901 Cells were transfected with miR-199a-3p mimics or NC and NCI-N87 transfected with anti-miR-199a-3p or anti-miR-NC at 24 h post-
transfection were subjected to WST assay. The results are means of three independent experiments ± S.D. (⁄P < 0.05, ⁄⁄P < 0.01). The effect of miR-199a-3p and anti-miR-199a-
3p on cell proliferation was assessed by the colony formation assay in SGC-7901 cells (C) and NCI-N87 cells (D). SGC-7901 Cells transfected with 100 nMmiR-199a-3p mimics
or control and NCI-N87 transfected inhibitors or control were seeded onto 6-well plates. The number of colonies was counted on the 14th day after seeding. Representative
photographs of colonies are shown in left panels. Relevant quantiﬁcation of the results is shown in the bar graphs. The results are means of three independent
experiments ± S.D. (⁄⁄P < 0.01).
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21.3% ± 3.1%, P < 0.05, Fig. 3A). On the contrary, the apoptotic rate
of miR-199a-3p inhibitor-transfected NCI-N87 cells was obviously
higher compared with the negative control (28.9% ± 1.2% VS
18.7% ± 3.4%, P < 0.01, Fig. 3B). However, there were no signiﬁcant
differences in the cell cycle between the different groups (data not
shown). These results suggest that overexpression of miR-199a-3p
inhibited apoptosis in GC cells, which may contribute to the
growth induction features of miR-199a-3p.
Cysteine-aspartic protease (caspase) 3 is responsible for regu-
lating and initiating apoptosis of mature cells, and the importance
of caspase-3 in GC has been conﬁrmed in many studies [16]. Thus,
we investigated the expression of caspase-3 to demonstrate the
inﬂuence of miR-199a-3p on GC cell apoptosis by regulating
caspase-3. The expression of caspase-3 did not show a signiﬁcantdifference among the different cell groups, while cleaved cas-
pase-3 showed remarkable differences. As shown in Fig. 4, the
expression of cleaved caspase-3 was signiﬁcantly lower in SGC-
7901 cells transfected with the miR-199a-3p mimics compared
with that in SGC-7901 cells transfected with the negative control.
NCI-N87 cells transfected with the miR-199a-3p inhibitors
showed higher expression of cleaved caspase-3 than NCI-N87 cells
transfected with the negative control.
3.4. MiR-199a-3p Directly targets ZHX1 30UTR to inhibit ZHX1
expression
To investigate new targets of miR-199a-3p and better knowing
the mechanisms underlying the tumor suppressive effect of
downregulation of miR-199a-3p in GC, the bioinformatics tools,
Fig. 3. Effect of miR-199a-3p on apoptosis in GC cells. (A) Representative histograms depicting apoptosis of SGC-7901 cells transiently transfected with 100 nMmiR-199a-3p
mimics or NC and parental cells (left panels). The percentage of apoptotic cells of three independent experiments ± S.D. are shown in the bar graphs (⁄P < 0.05). (B)
Representative histograms depicting apoptosis of NCI-N87 cells transiently transfected with 100 nM miR-199a-3p inhibitors or NC and parental cells (left panels). The
percentage of apoptotic cells of three independent experiments ± S.D. are shown in the bar graphs (⁄⁄P < 0.01).
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target search. Among numerous predicted candidate genes, the
transcription repressor ZHX1 is of special interest and showed
the highest score. Importantly, ZHX1 play a suppressive role in cell
growth in HCC [9], but the function of ZHX1 in GC has not been
reported yet.
Luciferase reporter assays were carried out to identify a direct
interaction between miR-199a-3p and the 30UTR of ZHX1. Wide-
type and mutated luciferase reporters were constructed (Fig. 4A).
The pMIR/ZHX1/wt and pMIR/ZHX1/mut luciferase reporter con-
structs were transfected into HEK 293T cells, along with miR-
199a-3p or NC mimics. The relative luciferase activity of the
pMIR/ZHX1/wt reporter was obviously inhibited (1.49 ± 0.41 VS
0.81 ± 0.24, P < 0.05; 0.75 ± 0.18 VS 0.79 ± 0.31, P > 0.05, Fig. 4B).
This result indicated that the 30UTR of ZHX1 contains direct binding
sites for miR-199a-3p. To determine whether miR-199a-3p down-
regulated ZHX1 at the mRNA and/or protein level, we examined
ZHX1 expression by qRT-PCR and Western blotting. As shown in
Fig. 4C higher panel, the ZHX1 protein level was lower in miR-
199a-3p mimics-transfected SGC-7901 cells compared with that
in the NC mimics-transfected cells. In Fig. 4C lower panel, ZHX1
protein level was higher in pEGFP-ZHX1-transfected SGC-
7901cells, which means up-regulate ZHX1 successfully by tran-
sient transfection. However, miR-199a-3p did have no impact on
ZHX1 mRNA level (Fig. 4D). These results suggested that miR-
199a-3p negatively regulates ZHX1 expression at the translational
level.
3.5. Downexpression of miR-199a-3p suppresses tumorigenicity and
promotes apoptosis in vivo
Given that downregulation of miR-199a-3p inhibits GC cell
proliferation and induces apoptosis in vitro, we identify whethersuppression of miR-199a-3p could suppress tumor growth and
induce apoptosis in vivo. NCI-N87 cells with LV-anti-miR-199a-
3p (NCI-N87/anti-miR) or LV-anti-miR-control (NCI-N87/anti-NC)
were acquired as indicated in the Materials and methods. Cells
were injected subcutaneously into nude mice. The tumor latency
time was signiﬁcantly different between the mice injected with
NCI-N87/anti-miR cells and those injected with NCI-N87/anti-NC
cells. Tumors derived from the NCI-N87/anti-miR cells grew sub-
stantially slower than those derived from the NCI-N87/anti-NC
cells throughout the tumor growth (1.41 ± 0.15 VS 0.68 ± 0.17,
P < 0.01, Fig. 5A and B). The average weight of tumors resulting
from NCI-N87/anti-miR cells was obviously lower than that of
tumors derived from NCI-N87/anti-NC cells (1.31 ± 0.52 VS
0.56 ± 0.12, P < 0.05, Fig. 5C and D).
The impact of miR-199a-3p on cell proliferation in tumors was
evaluated by examining the proliferative index of Ki-67. Immuno-
histochemistry staining suggested that the Ki-67 staining was sig-
niﬁcantly lower in the NCI-N87/anti-miR tumors compared with
that in the NCI-N87/miR-NC tumors. Additionally, TUNEL assays
on tumor tissues were examined. As shown in Fig. 5E and
F(71.3% ± 12.1% VS 21% ± 9.62%, P < 0.01; 26.1% ± 8.67% VS
119.2% ± 28.3%, P < 0.01), NCI-87/anti-miR cells showed a less
tumor cell positive staining and a signiﬁcantly higher apoptosis
index than the NCI-N87/anti-NC. These results indicated that
decreasing expression of miR-199a-3p contributed to inhibition of
tumorigenicity and promotion of apoptosis in vivo.
3.6. Overexpression of ZHX1 rescues effect of miR-199a-3p in GC cells
Because miR-199a-3p suppressed ZHX1 to induce cell prolifera-
tion and inhibit apoptosis, overexpression of ZHX1 could reverse
this phenomenon. Indeed, when the ZHX1 expression plasmid
(pEGFP-ZHX1) was imported into SGC-7901 cells transiently trans-
Fig. 4. MiR-199a-3p targets ZHX1 and inhibits caspase 3 expression. (A) Sequence of the ZHX1 30UTR showing the miR-199a-3p binding site and mutation of the ZHX1 30UTR
binding site to create ZHX1-mut. (B) miR-199a-3p inhibitors up-regulated luciferase activities controlled by wild-type ZHX1 30UTR (⁄P < 0.01), but did not affect luciferase
activity controlled by mutant ZHX1 30UTR. The results are means of three independent experiments ± S.D. (C) Representative Western blotting images of indicated protein in
SGC-7901 cells and NCI-N87 (left panels), with relevant quantiﬁcation (right panel). The results are means of three independent experiments ± S.D. (⁄P < 0.01, ⁄⁄P < 0.01) ZHX1
protein was detected in SGC-7901 transfected with pEGFP-ZHX1 and pEGFP-C1 (lower panel). The results are means of three independent experiments ± S.D. (⁄P < 0.01) (D)
ZHX1 mRNA in SGC-7901 cells and NCI-N87 were analyzed by RT-PCR at 48 h post-transfection with miR-199a-3p mimics or NC and miR-199a-3p inhibitors or NC.
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199a-3p on cell growth was partially reversed, assessed by the
WST cell growth assay (3.1 ± 0.2 VS 2.41 ± 0.34, 2.39 ± 2.19,Fig. 6A). Moreover, apoptosis rates were ampliﬁed when ZHX1
was overexpressed in SGC-7901 cells transfected with miR-199a-
3p mimics (14.3% ± 1.2%, 7.2% ± 1.31%, 21.7% ± 2.6%, Fig. 6B,C).
Fig. 5. Underexpression of miR-199a-3p inhibits tumorigenicity and increases apoptosis in vivo. (A and C) Photographs of tumors derived from NCI-N87/anti-NC and NCI-
N87/anti-miR in nude mice. (B) Average weight of tumors in nude mice. Means ± S.D. was shown (⁄⁄P < 0.01). (D) Growth kinetics of tumors in nude mice. Tumor diameters
were measured every 7 days. Bars ± S.D. (⁄⁄P < 0.01). (E–F) Representative photographs of immunohistochemical analysis of Ki-67 antigen in tumors of nude mice.
Representative image of TUNEL assay of tumor specimens from nude mice (original magniﬁcation, 200). Comparison of proliferation index. Means ± S.D. are shown
(⁄⁄P < 0.01). The percentage of apoptotic cells was counted. Columns, mean; bars, ±S.D. (⁄⁄P < 0.01).
4510 Z. Wang et al. / FEBS Letters 588 (2014) 4504–4512These data indicated that growth promotion and apoptosis inhibi-
tion by miR-199a-3p are related to ZHX1 expression.
4. Discussion
MiRNAs have an signiﬁcant role in regulating cellular activities.
They can profoundly affect the expression of a large number of
genes that encode proteins. Expression level of miR-199a-3p varies
among related cancers, resulting in different effects, e.g., miR-
199a-3p acts as a protective factor in HCC [9] while it can induce
cell proliferation in breast cancer [8]. MiR-199a had been reported
to be upregulated in GC tissues [12–14,17]. Previously, we demon-
strated that miR-199a-3p was upregulated in GC patients’ plasmacompared with normal people, and that plasma miR-199a-3p
may be a novel diagnostic biomarker for GC detection, even at early
stages [10,11]. Hence, we were interested in investigating the
mechanism by which miR-199a-3p affects the carcinogenesis of
GC.
In this study, we found that miR-199a-3p expressed much
higher in 69.2% of the GC samples, indicating that increased miR-
199a-3p expression is common in GC. Importantly, miR-199a-3p
levels positively associated with the TNM stage and the deeper
tumor invasion of GC patients. The functional studies suggested
that the expression of miR-199a-3p inhibitors in NCI-N87 cells
resulted in a signiﬁcant inhibitory effect on cell proliferation,
whereas a more aggressive phenotype in vitro resulted from
Fig. 6. Overexpression of ZHX1 rescues effect of miR-199a-3p in GC cells. Cells were transfected with miR-199a-3p mimics or control, together with ZHX1 expression vector
(pEGFP-ZHX1) or pEGFP-C1 at 24 h post-transfection were subjected to WST assay. Upon transfected with pEGFP-ZHX1, SGC-7901 (A) were partially rescued from miR-199a-
3p growth induction properties. Representative histograms depicting apoptosis SGC-7901 cells (B and C) transfected with miR-199a-3p mimics or control, together with
pEGFP-ZHX1 or pEGFP-C1 by ﬂow cytometry. The percentage of apoptotic cells of three independent experiments (⁄P < 0.01, ⁄⁄P < 0.01) are shown in the bar graphs.
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in vivo stable low expression of miR-199a-3p in NCI-N87 cells
showed a weaker ability to induce tumor growth compared with
the same cell lines transfected with the negative control vectors.
These results, together with other studies [18], suggested that
miR-199a-3p is a tumor-inducing miRNA in GC.
To better knowing the functional mechanism of miR-199a-3p as
a tumor-inducing miRNA, we used bioinformatics analyses to iden-
tify the genes downstream of miR-199a-3p. Smad4, klotho and
MAP3K11 had been proven to be direct targets of miR-199a-3p
[12–14]. Here, we demonstrated that ZHX1 is a brand new down-
stream target of miR-199a-3p, and that ZHX1 expression was reg-
ulated by miR-199a-3p via direct binding to the 30UTR of ZHX1.
This was supported by the fact that miR-199a-3p expression inhib-
ited the luciferase activity and ZHX1 protein expression, whereas
anti-miR-199a-3p expression promoted the ZHX1 protein expres-
sion. However, miR-199a-3p did not affect the ZHX1 mRNA level.
MiRNAs can modulate gene activity via decreasing gene translation
or increasing degradation of target mRNA [19]. ZHX1 belongs to the
zinc-ﬁngers class of homeodomain transcription factors, and its
function remains unclear [20,21] The ZHX1 gene has not been thor-
oughly investigated in the area of cancer. In HCC, Wang et al. [22]
have found that overexpression of ZHX1 in SMMC-7721 cells inhib-
ited proliferation, while reduced ZHX1 expression is widespread
among cancer tissues from HCC patients, and a low expression of
ZHX1 may be responsible for hepatocarcinogenesis.
Caspases are a set of cysteine-containing proteolytic enzymes
produced, which are associated with proliferation, cell migration
and organization. They execute apoptosis, and caspase-3 seems
to be the best-known member of the caspase family. The
importance of this caspase in GC has been conﬁrmed in numerous
studies and a great deal of research continues to be carried out. In
the present study, Western blot analysis demonstrated that upreg-
ulated miR-199a-3p in SGC-7901 cells suppressed the level ofcleaved caspase-3 protein compared with that in the negative con-
trol. Furthermore, downregulation of miR-199a-3p in NCI-N87
cells led to a higher expression level of cleaved caspase-3 than that
in the negative control. The change in cleaved caspase-3, the active
form of caspase-3, was inversely associated with the expression of
miR-199a-3p, which indicated that the growth of GC cells induced
by miR-199a-3p may partially be related to the suppression of cas-
pase-3 and its active form’s expression. At the same time, we
observed a corresponding change in cleaved caspase-3 after elevat-
ing ZHX1 expression in NCI-N87 cells. Importantly, overexpression
of ZHX1 rescued the miR-199a-3p-induced cell growth and cell
apoptosis inhibition, further suggesting that ZHX1 is a direct target
of miR-199a-3p, indicating an essential role for ZHX1 as a mediator
of the biological function of miR-199a-3p in GC.
In conclusion, we found that miR-199a-3p plays a tumor-induc-
ing role in GC cells. The inducing function of miR-199a-3p was
exerted by downregulating the protein expression of its direct tar-
get, ZHX1. Although miR-199a-3p’s function in cancer is not
entirely clear, our ﬁndings provided a novel molecular target and
mechanism of miR-199a-3p in GC. Therefore, miR-199a-3p could
be considered as a novel target for GC prevention and therapy.
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